Literature DB >> 21441473

Scientific approaches to AIDS prevention and control in China.

T Teng1, Y Shao.   

Abstract

The HIV epidemic in China started among intravenous drug users in the late 1980s. The second wave of the epidemic was caused by an outbreak in the paid plasma donors in central China in the mid-1990s. Sexually transmitted HIV cases have steadily increased and comprised more than half the reported HIV/AIDS infections since 2007. In the last 5 years, there has been a sharp increase of HIV infection in men who have sex with men. The HIV epidemic in China has expanded from high-risk groups to the general population and from rural regions to urban areas. This brief article discusses the history of HIV epidemics in China and the challenges facing the current AIDS control efforts in the country. It explains that only scientific approaches can sustain the national AIDS control programs and introduce the type of research needed to address those challenges. The selected research areas include molecular epidemiology, drug resistance surveillance, and the Chinese HIV vaccine research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441473     DOI: 10.1177/0022034511398871

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  16 in total

1.  Prevalence and correlates of sexual risk behaviors among drug users in western China: implications for HIV transmission.

Authors:  Jiegang Huang; Junjun Jiang; Jonathan Z Li; Xiaobo Yang; Wei Deng; Abu S Abdullah; Bo Qin; Halmurat Upur; Chaohui Zhong; Qianqiu Wang; Qian Wang; Yuhua Ruan; Yunfeng Zou; Li Ye; Peiyan Xie; Fumei Wei; Na Xu; Bo Wei; Hao Liang
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-13       Impact factor: 2.205

2.  HIV-1 transmission among injection drug users leads to novel recombinants circulating in southern China.

Authors:  Ke Zhao; Juan Du; Wenwen Zheng; Xiao-Fang Yu
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10       Impact factor: 2.205

3.  Advancing the prevention agenda for HIV and other sexually transmitted infections in south China: social science research to inform effective public health interventions.

Authors:  Kathryn E Muessig; M Kumi Smith; Suzanne Maman; Yingying Huang; Xiang-Sheng Chen
Journal:  AIDS Behav       Date:  2014-02

4.  The HIV-1 epidemic: low- to middle-income countries.

Authors:  Yiming Shao; Carolyn Williamson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

5.  Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12.

Authors:  Jianhui Nie; Juan Zhao; Qingqing Chen; Weijin Huang; Youchun Wang
Journal:  Virol Sin       Date:  2014-09-28       Impact factor: 4.327

6.  In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.

Authors:  Hao Wu; Xiao-Min Zhang; Hao-Jie Zhang; Qiwei Zhang; Zhiwei Chen; Jian-Dong Huang; Shui-Shan Lee; Bo-Jian Zheng
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01-08       Impact factor: 2.205

7.  Preoperative risk factors influencing the incidence of postoperative sepsis in human immunodeficiency virus-infected patients: a retrospective cohort study.

Authors:  Jinsong Su; Andy Tsun; Lei Zhang; Xianjun Xia; Bin Li; Ruizhang Guo; Baochi Liu
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

8.  Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China.

Authors:  Tongtong Liu; Xi Wang; Aixin Li; Jiangzhu Ye; Duo Shan; Guang Zhang; An Liu
Journal:  BMC Public Health       Date:  2021-06-24       Impact factor: 3.295

9.  Prevention and treatment of surgical site infection in HIV-infected patients.

Authors:  Lei Zhang; Bao-Chi Liu; Xiao-Yan Zhang; Lei Li; Xian-Jun Xia; Rui-Zhang Guo
Journal:  BMC Infect Dis       Date:  2012-05-14       Impact factor: 3.090

10.  Anti-infective treatment in HIV-infected patients during perioperative period.

Authors:  Baochi Liu; Lei Zhang; Ruizhang Guo; Jinsong Su; Lei Li; Yanhui Si
Journal:  AIDS Res Ther       Date:  2012-11-27       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.